ARTICLE | Clinical News
La Jolla Pharma preclinical data
December 19, 2005 8:00 AM UTC
In a rat model of stroke, LJP 1207 led to a marked reduction in the adhesion and infiltration of WBCs in blood vessels of brain after stroke and significantly reduced neurological damage. LJP 1207 is ...